Total Payments
$1,740
2024 Payments
$812.43
Companies
18
Transactions
83
Medicare Patients
1,971
Medicare Billing
$198,302
Payment Breakdown by Category
Food & Beverage$1,740 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,740 | 83 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $387.27 | 19 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $265.36 | 12 | $0 (2024) |
| QOL Medical, LLC | $180.75 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $138.34 | 7 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $138.18 | 6 | $0 (2017) |
| AbbVie, Inc. | $122.67 | 6 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $114.84 | 4 | $0 (2024) |
| Ardelyx, Inc. | $110.12 | 6 | $0 (2024) |
| Fresenius Kabi USA, LLC | $72.14 | 4 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $49.50 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $812.43 | 39 | Takeda Pharmaceuticals U.S.A., Inc. ($223.41) |
| 2023 | $413.89 | 17 | Takeda Pharmaceuticals U.S.A., Inc. ($126.93) |
| 2022 | $12.95 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($12.95) |
| 2020 | $22.41 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($22.41) |
| 2018 | $162.16 | 8 | AbbVie, Inc. ($100.05) |
| 2017 | $316.57 | 17 | Valeant Pharmaceuticals North America LLC ($138.18) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $2.95 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: Gastroenterology | ||||||
| 12/06/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $29.10 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $1.86 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $24.04 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), PLENVU | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Gastroenterology | ||||||
| 10/18/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 10/18/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 10/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/11/2024 | Laborie Medical Technologies Corp. | alpHaONE (Device) | Food and Beverage | Cash or cash equivalent | $16.04 | General |
| Category: Gastroenterology | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Gastroenterology | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $34.21 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Gastroenterology | ||||||
| 08/21/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Biosimilars | ||||||
| 08/06/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $25.80 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/23/2024 | Lilly USA, LLC | OMVOH (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 370 | 371 | $469,714 | $25,988 |
| 2022 | 5 | 295 | 306 | $354,206 | $29,365 |
| 2021 | 6 | 745 | 821 | $889,763 | $85,513 |
| 2020 | 7 | 561 | 578 | $612,137 | $57,435 |
Total Patients
1,971
Total Services
2,076
Medicare Billing
$198,302
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 198 | 199 | $255,514 | $13,754 | 5.4% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2023 | 75 | 75 | $78,570 | $5,013 | 6.4% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 59 | 59 | $78,072 | $4,292 | 5.5% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2023 | 38 | 38 | $57,558 | $2,929 | 5.1% |
| 00142 | Anesthesia for lens surgery | Facility | 2022 | 147 | 158 | $178,036 | $15,548 | 8.7% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 68 | 68 | $83,776 | $6,380 | 7.6% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 33 | 33 | $38,370 | $3,024 | 7.9% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 31 | 31 | $31,848 | $2,696 | 8.5% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2022 | 16 | 16 | $22,176 | $1,717 | 7.7% |
| 00142 | Anesthesia for lens surgery | Facility | 2021 | 617 | 693 | $789,057 | $75,008 | 9.5% |
| 00140 | Anesthesia for procedure on eye | Facility | 2021 | 22 | 22 | $28,162 | $2,778 | 9.9% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2021 | 34 | 34 | $19,119 | $2,367 | 12.4% |
| 00103 | Anesthesia for procedure on eyelid | Facility | 2021 | 15 | 15 | $21,407 | $2,066 | 9.6% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 29 | 29 | $16,712 | $1,729 | 10.3% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 28 | 28 | $15,307 | $1,565 | 10.2% |
| 00142 | Anesthesia for lens surgery | Facility | 2020 | 364 | 379 | $428,330 | $43,314 | 10.1% |
| 00140 | Anesthesia for procedure on eye | Facility | 2020 | 23 | 23 | $34,744 | $3,710 | 10.7% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 50 | 52 | $44,803 | $2,990 | 6.7% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2020 | 43 | 43 | $34,664 | $2,438 | 7.0% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2020 | 33 | 33 | $19,912 | $2,009 | 10.1% |
| 01810 | Anesthesia for procedure on nerves, muscles, tendons, fascia, and bursae of forearm, wrist, and hand | Facility | 2020 | 30 | 30 | $29,167 | $1,698 | 5.8% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2020 | 18 | 18 | $20,516 | $1,277 | 6.2% |
About Dr. Gilbert Fishbein, MD
Dr. Gilbert Fishbein, MD is a Anesthesiology healthcare provider based in Marlborough, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528058666.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gilbert Fishbein, MD has received a total of $1,740 in payments from pharmaceutical and medical device companies, with $812.43 received in 2024. These payments were reported across 83 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,740).
As a Medicare-enrolled provider, Fishbein has provided services to 1,971 Medicare beneficiaries, totaling 2,076 services with total Medicare billing of $198,302. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Location Marlborough, MA
- Active Since 10/27/2005
- Last Updated 10/28/2010
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1528058666
Products in Payments
- ENTYVIO (Biological) $268.57
- XIFAXAN (Drug) $198.89
- SUCRAID (Drug) $133.67
- Humira (Biological) $122.67
- DUPIXENT (Biological) $114.84
- IBSRELA (Drug) $110.12
- STELARA (Biological) $98.69
- IDACIO (Biological) $72.14
- RELISTOR (Drug) $53.71
- OCALIVA (Drug) $49.50
- GATTEX (Drug) $49.23
- TRULANCE (Drug) $48.49
- Sucraid (Drug) $47.08
- EOHILIA (Drug) $45.49
- MOVIPREP (Drug) $40.34
- SUTAB (Drug) $25.40
- OMVOH (Drug) $24.76
- TREMFYA (Drug) $23.87
- PLENVU (Drug) $22.41
- UCERIS TABLETS (Drug) $21.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.